James E. Levine
CIK 1463151 · Chief Financial Officer · last filed 2025-03-13
James E. Levine is a Chief Financial Officer who has filed 28 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for CRDF, was dated Mar 13, 2025. Across all open-market trades the lifetime net is +$757.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $193.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$193.0K
3
28
$757.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Chief Financial Officer | 125,316 | $1.54 | $193.0K | $277.4K | 8 | 2025-03-13 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Chief Financial Officer | 119,803 | $221.38 | $26.52M | $215.2K | 7 | 2021-03-19 |
| VERENIUM CORP (VRNM) Delisted | President & CEO | 109,166 | — | — | $265.2K | 12 | 2013-08-02 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-13 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-12-18 | CRDF | Buy (P) | +7,716 | $36.7K | EDGAR |
| 2024-03-07 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2023-03-16 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2022-09-19 | CRDF | Buy (P) | +30,000 | $46.7K | EDGAR |
| 2022-03-10 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2021-09-13 | CRDF | Buy (P) | +30,000 | $194.0K | EDGAR |
| 2021-07-12 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2021-03-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-12 | Cidara Therapeutics, Inc. (CDTX) Delisted | Buy (P) | +50,000 | $100.7K | EDGAR |